Hyloris Pharmaceuticals (EBR: HYL) stock: the official figures
Hyloris Pharmaceuticals is listed on Euronext Brussels under the ticker HYL and belongs to the health care sector. In fiscal 2025 it reported revenue of €7.2m and a net loss of €6.3m, according to the annual accounts it filed with the regulator.
Identifiers for Hyloris Pharmaceuticals: ISIN BE0974363955 · LEI 875500LZIWS7QEQE0I73.
Fiscal 2025 figures
| Item | 2025 | 2024 | Change |
|---|---|---|---|
| Revenue | €7.2m | €8.5m | −14.8% |
| Operating profit | −€6.8m | −€7.1m | — |
| Net profit | −€6.3m | −€6.3m | — |
| Earnings per share | −€0.23 | −€0.23 | — |
| Operating margin | −94.5% | −84.3% | −10.2 pts |
| Net margin | −87.9% | −75.0% | −12.9 pts |
| Total assets | €33.4m | €41.3m | −19.3% |
| Equity | €26.5m | €32.1m | −17.6% |
| Cash | €13.8m | €23.6m | −41.6% |
| Operating cash flow | −€7.0m | −€6.9m | — |
Margins are calculated from the filed figures: operating profit and net profit over revenue.
6 fiscal years
| Fiscal year | Revenue | Operating profit | Net profit | Earnings per share | Document |
|---|---|---|---|---|---|
| 2025 | €7.2m | −€6.8m | −€6.3m | −€0.23 | Annual report |
| 2024 | €8.5m | −€7.1m | −€6.3m | −€0.23 | Annual report |
| 2023 | €2.1m | −€16.0m | −€15.4m | −€0.55 | Annual report |
| 2022 | €0.9m | −€11.6m | −€11.9m | −€0.43 | — |
| 2021 | €3.1m | −€10.5m | −€11.6m | −€0.45 | Annual report |
| 2020 | €0.2m | −€7.0m | −€7.1m | −€0.33 | — |
The full income statement, balance sheet and cash flow statement are in the annual accounts of Hyloris Pharmaceuticals.
Frequently asked questions about Hyloris Pharmaceuticals
- How much did Hyloris Pharmaceuticals earn in fiscal 2025?
- Hyloris Pharmaceuticals reported a net loss of €6.3m for fiscal 2025, on revenue of €7.2m. The year before it reported a net loss of €6.3m.
- What are the earnings per share of Hyloris Pharmaceuticals?
- They were −€0.23 in fiscal 2025, compared with −€0.23 the year before.
- Where is Hyloris Pharmaceuticals listed?
- Hyloris Pharmaceuticals is listed on Euronext Brussels under the ticker HYL and belongs to the health care sector.
- What is the ISIN of Hyloris Pharmaceuticals?
- The ISIN of Hyloris Pharmaceuticals is BE0974363955, the international code that identifies its shares. Its LEI, the legal entity identifier, is 875500LZIWS7QEQE0I73.
- Where do the figures for Hyloris Pharmaceuticals come from?
- From the report Hyloris Pharmaceuticals files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.
Where each figure comes from
The annual accounts come from the report Hyloris Pharmaceuticals files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.